Amersham plc
Amersham plc
Amersham plc was a major pharmaceutical and biotechnology company based in the United Kingdom. It was known for its work in the fields of medical diagnostics and life sciences. The company played a significant role in the development of imaging agents and radioactive tracers used in medical imaging and research.
History
Amersham plc was originally founded as a public corporation in 1946 under the name "The Radiochemical Centre". It was established to produce radioisotopes for medical and industrial applications. Over the years, the company expanded its operations and product lines, becoming a leader in the field of nuclear medicine.
In 1982, the company was privatized and renamed Amersham International plc. It continued to grow through strategic acquisitions and partnerships, enhancing its capabilities in biotechnology and diagnostics.
Products and Services
Amersham plc was renowned for its innovative products in the areas of medical imaging and life sciences. Some of its key products included:
- Imaging agents: These are substances used to enhance the visibility of internal structures in medical imaging techniques such as X-ray, MRI, and CT scans.
- Radioactive tracers: These are used in nuclear medicine to diagnose and treat various diseases by tracking the movement of substances within the body.
- Biotechnology tools: Amersham provided a range of tools and reagents for genomics, proteomics, and cell biology research.
Acquisition by GE Healthcare
In 2004, Amersham plc was acquired by General Electric and became part of GE Healthcare. This acquisition allowed GE Healthcare to expand its portfolio in the healthcare sector, particularly in the areas of diagnostics and biosciences.
Legacy
Amersham plc's contributions to the fields of medical diagnostics and biotechnology have had a lasting impact on healthcare and scientific research. The company's innovations in imaging agents and radioactive tracers continue to be used in medical imaging and research worldwide.
Related Pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
